SCHEDULE 13D: Activist Investor Alex Meruelo Discloses 9.99% Stake in Bausch Health, Seeks Board Representation and Strategic Changes

Activist investor Alex Meruelo has disclosed a nearly 10% beneficial ownership stake in Bausch Health Companies Inc., signaling his intent to join the board and influence strategic decisions to enhance shareholder value.

Summary

• Alex Meruelo, through his Alex Meruelo Living Trust and Monterey Holdings, Inc., along with family members, has acquired 36,761,788 common shares of Bausch Health Companies Inc., representing 9.99% of the outstanding shares.
• The aggregate purchase price for these shares was approximately $285,173,070, funded by Mr. Meruelo's personal funds and those of his family members.
• Mr. Meruelo believes the securities were undervalued and represented an attractive investment opportunity.
• He has engaged with Bausch Health CEO Thomas Appio regarding the market reaction to the Issuer's recently announced debt refinancing, future debt maturities, and plans to maximize shareholder value.
• Mr. Meruelo has expressed his willingness to join the Issuer's board of directors and to help identify other strategic individuals to join the Board.
• He intends to continue discussions with the Issuer on critical matters including board composition, capital structure, capital allocation, and other opportunities to enhance stockholder value.
• If an agreement is not reached with the Issuer regarding board representation, Mr. Meruelo may seek to nominate such individuals to the Board.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a significant activist investor identifying the company as undervalued and seeking to enhance shareholder value through board representation and strategic changes. However, there's a moderate risk of potential conflict if an agreement isn't reached with management.

Positives

• A significant activist investor, Alex Meruelo, has identified Bausch Health's securities as 'undervalued' and an 'attractive investment opportunity,' potentially signaling a positive outlook for the company's future value.
• Mr. Meruelo, with over two decades of financial and business experience, has expressed willingness to join the board and help identify other strategic individuals, which could bring valuable expertise and oversight.
• His stated purpose is to actively engage with management and the board to enhance shareholder value through improvements in board composition, capital structure, and capital allocation.

Negatives

• The filing indicates a potential for conflict if Mr. Meruelo is unable to reach an agreement with the Issuer regarding board representation, which could lead to a proxy contest and potential disruption.

Risks

• Potential for disagreement between Mr. Meruelo and Bausch Health's current management or Board regarding strategic direction, board composition, or capital allocation, which could lead to internal friction.
• Risk of a proxy contest if Mr. Meruelo is unable to reach an amicable agreement to join the board or nominate other strategic individuals, potentially diverting management's focus and resources.
• The success of Mr. Meruelo's initiatives to enhance shareholder value is not guaranteed and depends on various factors, including overall market conditions, the Issuer's financial position, and the receptiveness of the current management and Board.

Future Outlook

Alex Meruelo intends to continue engaging with Bausch Health's management and Board regarding board composition, capital structure, capital allocation, and other opportunities to enhance stockholder value. He may seek to nominate individuals to the Board if an agreement is not reached and may increase or decrease his position in the Issuer based on various factors, including the Issuer's financial position, strategic direction, and overall market conditions.

Management Comments

• "Mr. Meruelo spoke with Thomas Appio, the Chief Executive Officer of the Issuer, regarding the market reaction to the Issuer's recently announced debt refinancing as well as the Issuer's future debt maturities and plans to maximize shareholder value."
• "It became clear to the Reporting Person that the Issuer could benefit from the Reporting Person's financial and business experience and, therefore, the Reporting Person expressed his willingness to join the board of directors of the Issuer and to help the Issuer identify other strategic individuals to join the Board."
• "The Reporting Person originally acquired the securities reported herein because he believed the securities were undervalued and represented an attractive investment opportunity."

Industry Context

This filing represents a significant activist stake taken by Alex Meruelo in Bausch Health Companies Inc., a common strategy employed by investors who identify undervalued companies or believe there are opportunities for operational or strategic improvements. Such actions often aim to influence corporate governance, capital allocation, and overall strategic direction, potentially leading to increased shareholder value, similar to other activist campaigns seen across various industries.

Legal Proceedings

• Mr. Meruelo has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
• Mr. Meruelo has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws, or finding any violation with respect to such laws, during the last five years.

Related Party Transactions

• The aggregate purchase price of the Shares was acquired with the personal funds of Mr. Meruelo and family members (Liset Meruelo, Alexander Meruelo, Alexis Meruelo, Lisette Meruelo, and Liset Meruelo's mother).
• Shares are held across various accounts including the Alex Meruelo Living Trust, Monterey Holdings, Inc., and individual/joint accounts of Liset Meruelo, Alexander Meruelo, Alexis Meruelo, and Lisette Meruelo.

Stakeholder Impact

• Shareholders: Potential positive impact through increased shareholder value if Mr. Meruelo's strategic initiatives are successfully implemented. There is also a potential for increased stock volatility if a proxy contest or significant strategic shifts occur.
• Management/Board: Increased scrutiny and potential for changes in leadership or strategic direction as Mr. Meruelo seeks board representation and influence over corporate strategy.
• Creditors: Potential impact on debt refinancing and future debt maturities, as Mr. Meruelo has discussed these topics with the CEO, aiming to maximize shareholder value which could involve changes to capital structure.

Next Steps

• Continue to engage with Bausch Health's management and Board regarding board composition, capital structure, and capital allocation.
• Potentially seek to nominate strategic individuals to the Board if an agreement is not reached with the Issuer.
• Review investment on a continuing basis and potentially increase or decrease his position in the Issuer's securities through open market or private transactions.
• Explore and prepare for various plans and actions, and propose transactions related to the Issuer's operations, management, organizational documents, ownership, corporate structure, and strategy.

Key Dates

Recommendation

Keywords

Bausch Health Companies Inc., Alex Meruelo, Schedule 13D, Activist Investor, Beneficial Ownership, Corporate Governance, Board Composition, Shareholder Value, Capital Structure, Debt Refinancing, Investment Opportunity